NeuroAiD(TM)II Holds Promise As A Safe Add-On Therapy to Standard Alzheimer Disease Symptomatic Treatments and May Have A Disease Modifying Effect by Delaying Disease Progression
Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical...
